Title | Houston Voice, No. 903, February 13, 1998 |
Contributor |
|
Publisher | Window Media |
Date | February 13, 1998 |
Language | English |
Subject |
|
Place |
|
Genre |
|
Type |
|
Identifier | OCLC: 31485329 |
Collection |
|
Rights | In Copyright |
Note | This item was digitized from materials loaned by the Gulf Coast Archive and Museum (GCAM). |
Title | File 008 |
Transcript | If you are experiencing disease-related weight loss and are finding it difficult to regain the weight, OXANDRIN may be an answer. OXANDRIN is an oral treatment that is available by prescription from your doctor. OXANDRIN helps stimulate the rebuilding of protein tissue in the body and promotes weight gain* OXANDRIN should be used in conjunction with proper nutrition and exercise. Now... a different treatment to help you gain weight To find out more about OXANDRIN, ask your doctor or call 1-800-741-2698. "Since I've been un OXANDRIN, I feel like I have my life back." Jamie f.— An actual person taking OXANDRIN OXANDRIN should be used only as directed by your physician. Precautions and Warnings from the OXANDRIN' (oxandrolone, USP) Clll Package Insert In patients receiving androgenic anabolic steroid therapy, 1) peliosis hepatis, a condition in which the liver and sometimes splenic tissue is replaced with blood-filled cysts, has been reported: 2) liver cell tumois are also reported; 3) blood lipid changes that are Known to be associated with increased risk ot atherosclerosis are seen. See Wimings and Precautions sections of complete presenbing information. CONTRAINDICATIONS: 1) known or suspected carcinoma ol the prostate or the male breast. 2) carcinoma ot the breast in temales with hypercalcemia (androgenic anabolic steroids may stimulate osteolytic bone resorption); 3) pregnancy, because ot possible masculinization of Ihe fetus. Oxandnn has been shown to cause embiyotoxicity. fetotoxicily. infertility, and masculinization of female animal offspring when given in doses 9 times the human dose; 4) nephrosis ot nephrotic phase ol nephritis. 5) hypercalcemia OXA-1635 ©19* BTG Pharmaceuticals. Please see important information on the following page. )X^NDRIN f oxandrolone, usp <jh 2,5 mg tablets The answer to disease-related weight loss* "After weight loss due to extensive surgery, chronic infection, severe trauma, failure to gam or maintain normal weight withoul definite pathophysiologic reasons, or protein catabolism due to prolonged corticosteroid administration. PAGE |
File Name | uhlib_31485329_n903_007.jpg |